Introduction
Tuberculosis remains a major infectious disease which accounts for approximately 3 million deaths per year worldwide. A series of effective drugs have been developed over several decades which have been recently challenged by two new circumstances: the first is the mutation of the tuberculosis genome to more lethal drug resistant forms, and the second is the association of tuberculosis with AIDS, both resulting in high mortality cases in such areas as KwaZulu-Natal in South Africa and in Europe and Asia.
No structures of infectious organisms have been described to date which correlate quantitatively and temporally with epidemic outbreaks, course, and lethality, and permit early or advance warning of such outbreaks. Replikins, first discovered in glioblastoma multiforme brain cancer cells rapidly replicating in tissue culture, are genomic structures related to rapid replication defined by the authors' algorithm: peptides 7 to 50 amino acids long, containing two or more lysines, six to ten amino acids apart, at least one histidine, and a lysine concentration of 6% or more (1, 7) . Replikins are the first reported conserved virus structures whose increasing concentration correlates quantitatively with, and predict, strainspecific virus outbreaks as well as their initial geographic location.
As observed in the 2009 H1N1 pandemic, advanced Replikins warning was published one year in advance, in April 2008 (3) (4) (5) . The outbreak occurred in April 2009. Because of the time taken to produce vaccine, vaccine was not available when the brunt of the pandemic struck in April 2009. Only 20% of the world's population at risk had vaccine available, and that was eight months after the outbreak, when the virus Replikin Count had already indicated that the lethal aspects of the pandemic would soon be over except for a brief recurrence in December 2010, also predicted. Fortunately, so far, the H1N1 pandemic has been less severe than the three pandemics in the last century. The 2011 outbreaks have begun for both H1N1 and H5N1. Initial 'scout' virus outbreaks of H1N1 have occurred, again in Mexico, with Replikin Counts of the Infectivity Gene up to a record 16.7 and a human mortality rate of 10.7%; and outbreaks of H5N1 in Egypt, better established, have begun with a current cumulative mortality rate of from 34.7% to 37.8% (WHO). It is generally agreed that new approaches are required for the control of acute emergent diseases.
The benefits of having more time to prepare for and to respond to acute lethal environmental events has been demonstrated in satellite warnings for hurricanes. The consequences of having little or no advance warning have been recently demonstrated in earthquaketsunamis and in the 2009 H1N1 influenza pandemic. While mutations can be detected, to date there have been no reliable technologies to predict emergence of specific virus or bacterial strains. The only global surveillance available is post outbreak and based solely on epidemiological data. Acute emergent infectious diseases coupled with current global travel pose challenges to timely implementation of public health measures such as tracking and isolation of cases, and the design, testing and distribution of specific effective vaccines and therapeutics to the world's population.
Methods
Software based on the authors' algorithm (9), has been used over the past decade mostly in influenza, but has now been successfully applied to other lethal pathogenic conditions such as tuberculosis, malaria and cancer. Replikins are first identified and then counted; the concentration of replikin peptides in each genomic sequence is counted (Replikin Count = number of replikins per 100 amino acids). For each group of specimens' replikins, the mean and standard deviation of the mean (SD) were calculated and compared. Highly statistically significant increases and decreases were examined, for example by strain, host, country, history, year, month or week; by substitution, morbidity, and lethality. The terms 'increase' and 'decrease' of Replikin Counts were used only when the p level was less than 0.001. During outbreaks, Replikin Counts were compared to Counts for the same strain in nonoutbreak ('resting') time periods. Statistical analyses of rate of change, trend, pattern, and growth models in the evolution of each virus strain were initiated. Replikin genes were isolated in silico by scanning and identifying those areas of the virus genome which had the highest concentration of replikins. When the genomic areas were examined year by year, gene areas were found which became upregulated when associated with particular outbreaks. When the upregulation was found to be associated with high infectivity (morbidity over time period), the high Count area was named Replikin Infectivity Gene. When a high Count area in a sequence was found to be associated with high mortality rates, the high Count area was named Replikin Lethality Gene. The Replikin Count of two genes in the influenza H1N1 virus were determined annually from 2001 to 2008 before the pandemic, then during the pandemic 'real-time' every few days, then weekly, from April 2009 to February 2011. Replikin peptides were visualized by two means: a) by linear display of sequences of contiguous numbered amino acids in the primary structure and b) by X-ray diffraction analysis of the 3-dimensional folded structure.
Results and Discussion
All sequences for tuberculosis on Pubmed were included in this analysis. Genomic Replikin Counts in influenza range from 0.1 to 4 for viruses not rapidly replicating and not producing outbreaks, over 4.0 to 10.0 or more for outbreaks with a minority of viruses, with occasional sequences having Counts of 20 to 30 (1). The Figure shows that the percent of each population of tuberculosis specimen genomes is in the same range. The percent of these tuberculosis populations which contain Replikins greater than 4.0 % is seen to increase from 1.9% for sequences from 'Fully Drug Sensitive' KZN4027 specimens, to 5.7 and 5.8 in Drug Resistant specimens, KZN1435 , KZNR506, to 6.3 in the 'avirulent' strain H37Ra and 6.7 in the 'virulent' strain H37Rc, to 12.7 in the "Extremely Drug Resistant" tuberculosis KZN605, sixfold greater than that of the 'Fully Drug Sensitive' genomes (see companion documents on malaria and cancer).
Earlier studies have shown that the increased concentration of this new class of virus genomic peptides, Replikins, precedes and predicts virus outbreaks and lethality (1) . The same phenomenon occurs in bacteria such as E. Coli (13) , and now in the tubercle bacillus. We now have found that the area in the genome of the highest concentration of Replikins, and the country in which this peak exists in scout viruses, have permitted in the past five years seven consecutive accurate predictions of the geographic localization of coming outbreaks (8) , including those now realized in Mexico for H1N1, and in Cambodia for H5N1. Real-time Replikin analysis of the evolution of the virus genome identified both mutations and structural reorganization of the hemagglutinin and p B1 genes over several years before each outbreak. This information, together with the specific Replikin sequences so obtained, permitted solid-phase synthesis of Replikin vaccines in seven days, which blocked Taura Syndrome Virus in shrimp (10) and blocked H5N1 in chickens (11) . The same principles are now being applied to the design and preparation of vaccines against highly lethal tuberculosis strains. The information also now provides up to two years of time to thoroughly test and distribute vaccines to high risk individuals in the countries identified; thus for the first time, a quantitative genomic Replikins method to both predict initial outbreaks and to prevent spread.
Lethal Replikins in Biology
The close relationship of genomic Replikin Count to morbidity and mortality in various hosts in biology has led to the hypothesis which we now consider, that Replikins, in addition to being closely involved in the biochemistry of rapid replication, are in fact infective units, intimately related to both infectivity and lethality in viruses, bacteria, and plasmodia, and to ethality in cancer cells, and that these various hosts are merely carriers of the Replikin nits. 
